Is cancer mortality increasing in France? by Hill, C et al.
In France, as in many other developed countries, cancer is the second
most common cause of death after cardiovascular diseases overall,
and it is the most common cause of death in the male population
since 1989. In 1997, 87 000 male deaths (32% of all deaths) were due
to cancer while cardiovascular diseases accounted for 29% of all
fatalities. In the female population, 56 000 deaths (22% of all deaths)
were due to cancer versus 36% caused by cardiovascular diseases
(http://sc8.vesinet.inserm.fr:1080/). 
National mortality statistics are the only source on which the
study of long-term trends in cancer can be based as there is no
national cancer registry in France. The regional registries cover
11% of a population totalling 58 millions, and do not dispose of
data for years prior to 1975 (Ménégoz and Chérié-Challine, 1998).
We present here a summary of trends in mortality between 1950
and 1997 for the most common cancer sites. 
In France, national death statistics based on death certificates
are published annually by cause, sex and age in 5-year age groups.
The quality of death certification has been improving over time:
18% of all death certificates bore no mention of any specified
cause in 1952 versus 6% in 1997. 
Estimates of the size of the population, by sex and age are
published yearly by the Institut National de la Statistique et des
Etudes Economiques (Bilan démographique, 1998) and are also
available on www.ined.fr. Mortality rates have been standardised
on the standard European population (www.iarc.fr). 
Between 1950 and 1997, the number of cancer deaths doubled in
France, increasing from 73 000 to 143 000. A large part of this rise
is due to an increase from 42 to 58 million in the size of the popula-
tion, and to a greater proportion of individuals aged 70 or over
(from 7% to 11%). The age-adjusted mortality rate per 100 000
increased by 13% from 175 to 198 once these effects are removed. 
Overall, cancer mortality rose in the male population from 200
per 100 000 inhabitants in 1950 to a maximum of 306 in 1987, and
subsequently declined to 273 per 100 000 in 1997. In the female
population, cancer mortality remained stable between 1950 and
1968 at around 150 per 100 000, and decreased regularly thereafter,
to 123 per 100 000 in 1997 (Figure 1). 
Figure 2 depicts the trends in the male and female populations,
for the main sites of cancer. Mortality is increasing for a few sites
and decreasing or stable for most sites. 
Cancer sites for which mortality is increasing, at least
for one sex 
Lung cancer mortality increased markedly in the male popula-
tion until the late 1980s, and has stabilised since but is still the
most common cause of cancer in males (25% of cancer deaths).
This pattern of progression in risk followed by stabilisation is
observed in all age groups. In the female population, lung
cancer mortality has doubled during the last 35 years, with an
accelerated increase during the last 10 years and in the popula-
tion aged 35 to 49. Notwithstanding, lung cancer remains rela-
tively uncommon in France in the female population (7% of
cancer deaths). Tobacco is the main risk factor. Its consumption
rose until 1985, attaining a maximum of 6.8 g per adult (age 15 +)
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per day, and decreased subsequently to 5.5 g in 2000. The
proportion of regular smokers between 1953 and 1998
decreased from 72% to 39% in the male population and
increased from 17% to 26% in the female population. The recent
stability in male mortality is probably the consequence of the
reduction in the proportion of smokers and of widespread use of
filtered and lighter cigarettes. In 1950, less than 5% of cigarettes
had a filter versus 90% today and the average tar content has
markedly decreased from 35 mg in 1950 to 10 mg today,
although the tar content as measured according to the
International Standard does not reflect the amount inhaled by a
smoker who tends to compensate for a low nicotine and tar
delivery by increasing smoke intake. French women started
smoking en masse in the late 1960s, which explains the recent
increase recorded in tobacco consumption and low mortality
due to lung cancer among women, for the time being. 
Mortality also increased among less common cancers not
shown on Figure 1: lymphoma, multiple myeloma, brain
tumours and skin melanoma. Mortality due to lymphoma
increased moderately until 1978 and then more markedly there-
after, with greater progression in the population aged 70 or over.
Mortality due to multiple myeloma rose regularly until the mid
1980s and is stable since. Mortality caused by brain tumours
increased regularly, except during the last few years where it
seems to have stabilised; the increase is larger in the population
aged 70 or over and from 1980 onwards, as the use of CT scan
became widespread. Mortality due to skin melanoma has
increased markedly with a concomitant decrease in mortality
due to non-melanomatous skin cancer, consequently the total
mortality due to skin cancer decreased until 1970 and is stable
since. This suggests that the increase observed for melanoma
stems essentially from better certification of the causes of death
with fewer certificates mentioning ‘skin cancer not otherwise
specified’. 
Cancer sites for which mortality is decreasing or stable 
After a steady increase between 1950 and 1976, mortality due to
mouth,  pharynx,  larynx and  oesophageal cancer in the male 
population steadily returned to its 1950 level. In the female popula-
tion, mortality is relatively stable for these sites. Despite the recent
decrease observed in the male population, mortality due to head and
neck cancer remains one of the highest in the world, among both
males and females. The death rate is 9-fold higher in males than in
females (ratio of standardised rates). Alcohol and tobacco are the
main causes of these cancers in France (Schwartz et al, 1962; Tuyns
et al, 1977; Brugère et al, 1986; Guénel et al, 1988; Launoy et al,
1997), where, traditionally, alcohol consumption is extremely high in
men. In 1950, the average consumption per adult (age 15 or over) per
day was 5 units (50 g of pure alcohol) compared to 1.4 units in the
UK or in the USA. From 1950 to 1995, the consumption of alcohol
dropped markedly to 3.2 units. This diminution explains probably a
large part of the decrease in mortality, additional factors are the
reduction in smoking prevalence among men and the increased
consumption of fresh fruits and vegetables. 
Mortality due to stomach cancer decreased steadily and substan-
tially in the male and female population. This decrease has been
observed in most developed countries and is attributed to a reduction
in Helicobacter pylori infection, to an increase in consumption of
fruits and vegetable (Hill, 1990) and to the generalisation of refriger-
ated food conservation, which has correspondingly reduced the
consumption of aliments with a high salt and nitrate content. 
Between 1950 and the mid 1970s, colorectal cancer mortality
increased moderately in the male population while a slight decline
was observed in the female population. Since the mid 1970s,
colorectal cancer mortality has decreased and to a greater extent in
the female than in the male population. This decrease may be due
to a wider use of surgery as the primary treatment, screening
remains marginal. 
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Mortality due to cancer of the uterus (corpus plus cervix) has
decreased regularly since 1960. It is not possible to study corpus
and cervix uteri cancer mortality separately before 1968 because
the same code was assigned to the corpus and to ‘uterus unspeci-
fied’. From 1968 onwards, cervix and corpus uteri mortality were
estimated separately, by multiplying the age-specific ratio between
cervix and cervix + corpus cancers by the age-specific total uterine
cancer mortality (“uterus unspecified” representing 60% of the
total). The decrease in mortality is greater for the cervix uteri than
for the corpus uteri, and is certainly at least partly attributable to
cervical cancer screening which has been largely used for more
than 20 years; in 1991, 79% of the women aged 25 to 54 reported
having had a smear in the previous 3 years. 
Prostate cancer mortality has been decreasing moderately and
regularly since 1989. It increased markedly in the 1950s and
moderately between 1960 and 1989. This rise was observed only
in the population aged 85 + which accounts for one third of the
prostate cancer-related deaths; it may be explained by an improve-
ment in the quality of the diagnosis and death certification. 
Ovary cancer mortality has been decreasing moderately since
1987. The increase observed before 1987 is probably largely
attributable to improvements in the diagnosis. The recent decrease
is partly explained by an extensive use of oral contraceptives since
1976. 
Since 1986, breast cancer mortality is stable; it had increased
markedly before. These trends are observed in all age groups.
Breast cancer is by far the overriding cause of cancer-related
mortality in the female population (19% of cancer deaths). Its inci-
dence was found to have increased by 60% between 1975 and
1995 (Ménégoz and Chérié-Challine, 1998). This increase in inci-
dence is mainly due to screening which has been freely accessible
in France for many years. In 1991, 27% of French women aged 40
to 69 reported having had a mammogram in the last 3 years versus
7% of the women in the UK. In 1993, 56% of women between age
50 and 69 reported having had a mammogram in the last 3 years
versus 73% in 1999. The decrease in mortality observed recently
in the UK and in the USA (Peto et al, 2000) is not observed in
France where mortality is much lower than in the UK, may be
because breast cancer has been treated more aggressively in
France for a long time. Tamoxifen has been prescribed to women
having a breast cancer after menopause with positive oestrogen
receptors since the early 1980s and chemotherapy has been used
extensively in France since 1985. 
Since 1992, liver cancer mortality has stabilised in the male
population, after a moderate increase. Liver cancer mortality
decreased between 1968 and 1984 in the female population, and
has stabilised since. The increase observed in the male population
prior to 1992, could be due to better diagnosis of liver cancer in
cirrhotic patients, and is unlikely to be related to hepatitis C infec-
tion since there has been no increase in women. The proportion of
liver cancers that are not specified as primary on the death certifi-
cates has declined regularly between 1968 and 1997 from 87% to
21% for males and from 90% to 26% for females, and the trends
analysed include these liver cancers unspecified as primary or
secondary. 
After regularly increasing, bladder cancer mortality has
stabilised in the male and female population since 1977. 
Among less common sites of cancer, it is noteworthy that renal
cancer mortality has stabilised and that leukaemia and thyroid
cancer mortality are decreasing. Renal cancer mortality rate has
been stable for the last several years. Leukaemia mortality has
been decreasing since the late 1970s after an earlier increase.
Thyroid cancer mortality has been decreasing since the mid 1980s,
after a slight increase. Its incidence increased markedly between
1975 and 1995 because of improved diagnosis leading to the
discovery of small nodules. This increase cannot be attributed to
the 1986 Chernobyl accident because it began 10 years before the
accident and is not associated with an increase in mortality. 
CONCLUSION 
Overall, cancer mortality has increased by 13% since 1950.
Among males, mortality increased between 1950 and 1987,
followed by a decrease. Among females, cancer mortality was
stable between 1950 and 1968 and since then has decreased
moderately. 
The initial increase among males is largely due to tobacco. The
decrease observed afterwards is attributed to reduced exposure to
alcohol and other carcinogens such as Helicobacter pylori infec-
tion, to an increase in protective factors such as fruit and vegetable
consumption, and to improvements in treatments and diagnosis.
Further improvements in therapy or screening and use of new
diagnostic tools should lead to persistently declining mortality
rates, unless the tobacco epidemic reverses the trend in female
mortality. 
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